The need for RCTs in immunotherapy for mesothelioma
Speaking from the 2018 European Lung Cancer Congress (ELCC) in Geneva, Switzerland, Dean Fennell, PhD, FRCP, of the University of Leicester, Leicester, UK, stresses the need for increased randomized c...
Author: VJOncology
Added: 08/29/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts
More News: Asbestosis | Cancer | Cancer & Oncology | Immunotherapy | Lung Cancer | Mesothelioma | Politics | Switzerland Health